Genfit
Clinical trials sponsored by Genfit, explained in plain language.
A biopharmaceutical company developing treatments for liver diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Experimental liver drug shows early promise but trial cut short
Disease control TerminatedThis early study tested a drug called VS-01 in 15 adults with acute-on-chronic liver failure (a sudden worsening of liver function) and fluid buildup in the belly. Participants received either VS-01 plus standard care or standard care alone. The trial was terminated early, so we …
Phase: PHASE2 • Sponsor: Genfit • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Liver drug trial halted after just 3 patients
Disease control TerminatedThis study tested a drug called VS-01 for people with severe confusion caused by liver disease (overt hepatic encephalopathy). The trial planned to enroll many participants but was stopped early after only 3 people joined. Researchers wanted to see if VS-01 could help patients re…
Phase: PHASE2 • Sponsor: Genfit • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC